Page last updated: 2024-08-21

hesperidin and Obesity

hesperidin has been researched along with Obesity in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (7.69)29.6817
2010's10 (38.46)24.3611
2020's14 (53.85)2.80

Authors

AuthorsStudies
Fujimura, Y; Haseda, A; Hattori, H; Kondo, S; Kumazoe, M; Nakasone, A; Nishihira, J; Shimamoto, Y; Tachibana, H; Yamamoto, M; Yonekura, M; Yoshitomi, R1
Akour, A; Al-Tammemi, AB; AlMuhaissen, SA; Alrawashdeh, MN; An, H; Anastasia, L; Apkon, S; Armstrong, WS; Ayala Izurieta, JE; Barnett, K; Bhowmick, S; Biniskos, N; Booka, E; Brown, JC; Buchanan, SW; Campbell, C; Camporeale, A; Cantos, VD; Cao, Z; Chakraborty, RD; Chaturvedi, V; Chen, C; Chen, G; Chen, Y; Chou, PT; Ciconte, G; Colasanti, JA; Collins, LF; Darras, BT; de Carvalho, RM; De Morais, DC; Delegido, J; Dodd, J; Doki, Y; Dunfield, K; Elfring, G; Feng, B; Ferry, VE; Galaviz, KI; García, VJ; Greven, M; Guo, J; Gutierrez, M; Hameed, S; Hippler, M; Huang, JW; Isaac, ME; Ishihara, R; Ishikawa, H; Ito, Y; Jacobson, A; Jalouqa, S; James, TD; Jara Santillán, CA; Jiang, K; Jordan, R; Kampf, JW; Kato, H; Kato, K; Katzmarzyk, PT; Kaviani, A; Kawachi, H; Kawakubo, H; Khansari Nejad, N; Kitagawa, Y; Kojima, T; Kono, K; Koplowitz, B; Kubo, Y; Kuribayashi, S; Lahiri, CD; Lei, H; Leighton, C; Li, J; Liu, G; Lombardi, M; Lu, Y; Luo, Y; Ma, P; Mafa-Attoye, T; Mahmoud, NN; Makhlina, M; Makino, T; Manguso, F; Mano, M; Manso, AP; Marconi, VC; Márquez, CO; Matsubara, H; Matsuda, S; McDonald, CM; Mecarocci, V; Metcalfe, GD; Micaglio, E; Miele, L; Mire, EF; Miyazaki, T; Moi, CT; Moore, CM; Moran, CA; Muto, M; Nemoto, K; Nguyen, ML; Nusair, MB; Ochoa, A; Owen, G; Oyama, T; Palma-Dibb, RG; Pappone, C; Parsons, JA; Pasqualotto, N; Peltz, SW; Pesco Koplowitz, L; Pica, S; Postiglione, WM; Qureshi, M; Rhodes, J; Saeki, H; Sakai, M; Santinelli, V; Santos, C; Shah, NS; Shanahan, JP; Shieh, PB; Sisti, JM; Smith, TW; Sohda, M; Song, Y; Spana, C; Sturla, F; Su, BK; Sumitani, J; Szabo, B; Szymczak, NK; Tabiś, W; Takeuchi, H; Tang, X; Thevathasan, NV; Toh, Y; Tondi, L; Trifillis, P; Tsushima, T; Van Wittenberghe, S; Vicedomini, G; Wang, H; Wang, K; Wang, S; Wang, W; Wang, X; Wang, Y; Wu, F; Wu, X; Yamaji, T; Yamamoto, K; Yamatsuji, T; Yang, L; Yang, S; Yang, WH; Yang, Y; Yoshida, M; Yu, B; Yuan, L; Zabaleta, J; Zhang, C; Zhang, H; Zhang, L; Zhang, X; Zhang, Z; Zheng, WQ; Zheng, YX; Zhou, H; Zhou, J; Zhou, N; Zhu, W1
Chen, TC; Ho, YY; Ke, YC; Lin, FH; Lin, JN; Tang, RC; Yang, IH1
Rabbani, N; Thornalley, PJ1
Banerjee, S; Biswas, S; Chanda, J; Kar, A; Mukherjee, PK; Tiwari, A; Ulrich-Merzenich, G1
Le, TT; Urasaki, Y1
Li, X; Li, Y; Liang, H; Liu, K; Liu, S; Ma, Z; Wang, Y; Wu, C; Xiao, Y; Yu, J; Zhou, L1
Chen, Q; Hu, K; Li, H; Li, W; Shi, J1
Akash, MSH; Arafa, EA; Buabeid, MA; Chohan, TA; Jabeen, K; Munawar, SM; Rehman, K; Tariq, M1
Gan, Q; Hu, J; Huang, Q; Lou, G; Peng, C; Ran, Q; Sun, J; Wang, J; Xiong, H; Yao, R1
Caimari, A; Crescenti, A; Del Bas, JM; Domenech-Coca, C; Escoté, X; Mas-Capdevila, A; Teichenne, J1
Liu, H; Lu, JF; Peng, L; Shi, X; Wang, YL; Wu, JW; Xia, B; Zhang, H; Zhu, MQ1
Bai, YF; Fan, XY; Lou, LJ; Sheng, H; Wang, SW; Weng, YY; Zhang, F1
Kurokawa, M; Sugita, C; Tsuhako, R; Yoshida, H1
Rabbani, N; Thornalley, PJ; Weickert, MO; Xue, M1
Chen, K; Chen, X; He, Q; Li, X; Liu, Y; Ma, J; Si, M; Sun, C; Wu, H; Yan, Y; Yang, B; Zhu, D1
Pu, P1
Mosqueda-Solís, A; Palou, A; Picó, C; Portillo, MP; Sánchez, J1
Murosaki, S; Muroyama, K; Ohara, T; Yamamoto, Y2
Anwar, A; Fowler, M; Jenkins, G; Kandala, NB; Messenger, D; Qureshi, S; Rabbani, N; Shafie, A; Thornalley, PJ; Waldron, M; Weickert, MO; Xue, M1
de Groot, E; Garcés-Rimón, M; Masclee, AA; Possemiers, S; Salden, BN; Stevens, YR; Troost, FJ; Winkens, B1
Avril, L; Boussetta, S; Enriquez Vega, DM; Guex, JJ; Taïeb, C1
Holland, LJ; Jackson, DE; Manthey, JA; Nichols, LA; Shukla, SD1
Freuchet, B; Jeusette, I; Le Bloc'h, J; Leray, V; Nguyen, P; Torre, C1
Kirienko, AI; Oganov, RG; Savel'ev, VS; Shal'nova, SA; Zolotukhin, IA1

Reviews

4 review(s) available for hesperidin and Obesity

ArticleYear
    Biomaterial investigations in dentistry, 2021, Volume: 8, Issue:1

    Topics: Adult; Alcohol Drinking; Ammonia; Animals; Anti-Inflammatory Agents; Area Under Curve; B-Lymphocytes; Black or African American; Bleaching Agents; Body Mass Index; Brugada Syndrome; Carbon; China; Climate Models; Codon, Nonsense; Cohort Studies; Colitis; Colon; COVID-19; Cytokines; Dental Enamel; Dextran Sulfate; Disease Models, Animal; Disease Outbreaks; Dogs; Electrocardiography; Escherichia coli; Esophageal Neoplasms; Female; Follow-Up Studies; Forests; Georgia; Glucosides; Healthy Volunteers; Heart Ventricles; Hesperidin; HIV Infections; Humans; Humidity; Hydrogen Peroxide; Incidence; Influenza, Human; Longitudinal Studies; Magnetic Resonance Imaging, Cine; Male; Melanocortins; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Middle Aged; Muscular Dystrophy, Duchenne; Naphthol AS D Esterase; Naphthols; Neoplasms; Nitrates; Nitrites; Nitrous Oxide; Obesity; Pandemics; Patient Outcome Assessment; Patient Satisfaction; Plants; Prednisolone; Prednisone; Pregnenediones; Proportional Hazards Models; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Rats; Receptor, Melanocortin, Type 1; Retrospective Studies; Risk Factors; SARS-CoV-2; Seasons; Soil; Stroke Volume; T-Lymphocytes; Telemedicine; Temperature; Tetralogy of Fallot; Tooth Bleaching; Tooth Bleaching Agents; Trees; Urea; White People

2021
Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
    International journal of molecular sciences, 2022, Feb-23, Volume: 23, Issue:5

    Topics: Animals; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Enzyme Induction; Glutathione; Glycosylation; Hesperidin; Humans; Insulin Resistance; Lactoylglutathione Lyase; Mice; Molecular Structure; Neoplasms, Experimental; Obesity; Pyruvaldehyde; Resveratrol

2022
Hesperidin: A Therapeutic Agent For Obesity.
    Drug design, development and therapy, 2019, Volume: 13

    Topics: Antioxidants; Diabetes Mellitus, Type 2; Hesperidin; Humans; Hypoglycemic Agents; Obesity

2019
Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.
    Nutrients, 2020, May-20, Volume: 12, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Biological Availability; Cardiovascular Diseases; Cardiovascular System; Citrus; Dysbiosis; Dyslipidemias; Flavanones; Gastrointestinal Microbiome; Hesperidin; Humans; Obesity; Risk Factors

2020

Trials

7 trial(s) available for hesperidin and Obesity

ArticleYear
The combined effect of green tea and α-glucosyl hesperidin in preventing obesity: a randomized placebo-controlled clinical trial.
    Scientific reports, 2021, 09-24, Volume: 11, Issue:1

    Topics: Adult; Body Mass Index; Catechin; Female; Glucosides; Hesperidin; Humans; Male; Middle Aged; Obesity; Placebos; Tea

2021
Reversal of Insulin Resistance in Overweight and Obese Subjects by
    Nutrients, 2021, Jul-11, Volume: 13, Issue:7

    Topics: Adult; Blood Pressure; Body Mass Index; Carrier Proteins; Correlation of Data; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glucose Metabolism Disorders; Glycosylation; Hesperidin; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Leukocytes, Mononuclear; Male; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Tumor Necrosis Factor-alpha

2021
Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial.
    Nutrition journal, 2016, Jan-19, Volume: 15

    Topics: Abdominal Fat; Adiposity; Adult; Aged; Anti-Obesity Agents; Body Mass Index; Caffeine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Glucosides; Hesperidin; Humans; Male; Middle Aged; Obesity; Sensitivity and Specificity; Subcutaneous Fat; Surveys and Questionnaires; Triglycerides; Walking; Young Adult

2016
Improved Glycemic Control and Vascular Function in Overweight and Obese Subjects by Glyoxalase 1 Inducer Formulation.
    Diabetes, 2016, Volume: 65, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose; Cell Line; Cross-Over Studies; Female; Glutathione; Glutathione Disulfide; Hep G2 Cells; Hesperidin; Humans; Lactoylglutathione Lyase; Male; Middle Aged; Models, Biological; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Stilbenes; Young Adult

2016
Randomized clinical trial on the efficacy of hesperidin 2S on validated cardiovascular biomarkers in healthy overweight individuals.
    The American journal of clinical nutrition, 2016, Volume: 104, Issue:6

    Topics: Adult; Aged; Biomarkers; Blood Pressure; Body Mass Index; Cardiovascular Diseases; Cell Adhesion Molecules; Dietary Supplements; Double-Blind Method; Down-Regulation; Endothelium, Vascular; Female; Hesperidin; Humans; Male; Middle Aged; Obesity; Overweight; P-Selectin; Postprandial Period; Treatment Outcome; Vascular Cell Adhesion Molecule-1

2016
Assessment of quality of life in Mexican patients suffering from chronic venous disorder - impact of oral Ruscus aculeatus-hesperidin-methyl-chalcone-ascorbic acid treatment - 'QUALITY Study'.
    Phlebology, 2009, Volume: 24, Issue:4

    Topics: Administration, Oral; Adult; Ascorbic Acid; Body Mass Index; Chalcone; Chronic Disease; Drug Therapy, Combination; Female; Hesperidin; Humans; Male; Mexico; Middle Aged; Obesity; Plant Extracts; Prospective Studies; Quality of Life; Ruscus; Surveys and Questionnaires; Vascular Diseases

2009
Effect of citrus polyphenol- and curcumin-supplemented diet on inflammatory state in obese cats.
    The British journal of nutrition, 2011, Volume: 106 Suppl 1

    Topics: Acute-Phase Proteins; Animals; Cat Diseases; Cats; Citrus; Cross-Over Studies; Curcumin; Cytokines; Female; Flavanones; Gene Expression Regulation; Hesperidin; Inflammation; Leukocytes, Mononuclear; Male; Obesity; RNA, Messenger

2011

Other Studies

15 other study(ies) available for hesperidin and Obesity

ArticleYear
Thiolated Chitosan as an Intestinal Absorption Carrier with Hesperidin Encapsulation for Obesity Treatment.
    Nutrients, 2021, Dec-09, Volume: 13, Issue:12

    Topics: Animals; Cells, Cultured; Chitosan; Disulfides; Drug Delivery Systems; Gastrointestinal Tract; Hesperidin; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Male; Mice, Inbred C57BL; Nutrients; Obesity; Thioglycolates

2021
Combining LC-MS/MS profiles with network pharmacology to predict molecular mechanisms of the hyperlipidemic activity of Lagenaria siceraria stand.
    Journal of ethnopharmacology, 2023, Jan-10, Volume: 300

    Topics: Animals; Atorvastatin; Chromatography, Liquid; Cucurbita; Flavonoids; Glycosides; Hesperidin; Hyperlipidemias; Hypertension; Insulins; Network Pharmacology; Obesity; Plant Extracts; Proto-Oncogene Proteins c-akt; Rats; Tandem Mass Spectrometry

2023
Functional Complementation of Anti-Adipogenic Phytonutrients for Obesity Prevention and Management.
    Nutrients, 2022, Oct-16, Volume: 14, Issue:20

    Topics: Adipocytes; Adipogenesis; Animals; Berberine; beta Catenin; Cholesterol; Curcumin; Cytokines; Fatty Acids; Glucose; Hesperidin; Humans; Lipoproteins, LDL; Luteolin; Mice; Obesity; Phytochemicals; PPAR gamma; Quercetin; Resveratrol; Sterol Regulatory Element Binding Protein 1; Triglycerides

2022
Hesperidin methyl chalcone ameliorates lipid metabolic disorders by activating lipase activity and increasing energy metabolism.
    Biochimica et biophysica acta. Molecular basis of disease, 2023, Volume: 1869, Issue:2

    Topics: Animals; Chalcones; Energy Metabolism; Flavonoids; Hesperidin; Lipase; Lipid Metabolism Disorders; Lipids; Mice; Obesity

2023
Hesperidin inhibits methylation and autophagy in LPS and high glucose-induced human villous trophoblasts.
    Biochemical and biophysical research communications, 2023, 09-03, Volume: 671

    Topics: Autophagy; Diabetes, Gestational; Female; Glucose; Hesperidin; Humans; Inflammation; Lipopolysaccharides; Methylation; Molecular Docking Simulation; Obesity; Placenta; Pregnancy; Trophoblasts

2023
Hesperidin improves insulin resistance via down-regulation of inflammatory responses: Biochemical analysis and in silico validation.
    PloS one, 2020, Volume: 15, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Diet, High-Fat; Disease Models, Animal; Drug Therapy, Combination; Hesperidin; Hyperlipidemias; Inflammation; Insulin Resistance; Leptin; Molecular Docking Simulation; Molecular Dynamics Simulation; Obesity; Orlistat; Rats, Wistar

2020
Neohesperidin attenuates obesity by altering the composition of the gut microbiota in high-fat diet-fed mice.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020, Volume: 34, Issue:9

    Topics: Animals; Bacteroidetes; Diet, High-Fat; Firmicutes; Gastrointestinal Microbiome; Hesperidin; Male; Mice; Obesity

2020
Neohesperidin enhances PGC-1α-mediated mitochondrial biogenesis and alleviates hepatic steatosis in high fat diet fed mice.
    Nutrition & diabetes, 2020, 08-05, Volume: 10, Issue:1

    Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Diet, High-Fat; Fatty Liver; Hep G2 Cells; Hesperidin; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Mitochondria; Non-alcoholic Fatty Liver Disease; Obesity; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha

2020
Glucosyl Hesperidin Has an Anti-diabetic Effect in High-Fat Diet-Induced Obese Mice.
    Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:3

    Topics: 3T3-L1 Cells; Adipose Tissue; Animals; Chemokine CCL2; Coculture Techniques; Diet, High-Fat; Disease Models, Animal; Glucosides; Hesperidin; Hyperglycemia; Hypoglycemic Agents; Macrophages; Male; Mice; Mice, Inbred C57BL; Obesity; RAW 264.7 Cells

2021
Neohesperidin Exerts Lipid-Regulating Effects in vitro and in vivo via Fibroblast Growth Factor 21 and AMP-Activated Protein Kinase/Sirtuin Type 1/Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1α Signaling Axis.
    Pharmacology, 2017, Volume: 100, Issue:3-4

    Topics: AMP-Activated Protein Kinases; Animals; Body Weight; Dyslipidemias; Fibroblast Growth Factors; Hep G2 Cells; Hesperidin; Humans; Lipid Metabolism; Liver; Mice, Inbred C57BL; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; RNA, Small Interfering; Sirtuin 1

2017
[Protection mechanisms of hesperidin on mouse with insulin resistance].
    Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2016, Volume: 41, Issue:17

    Topics: Animals; Blood Glucose; Diet, High-Fat; Hesperidin; Hyperglycemia; Hyperlipidemias; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Signal Transduction

2016
Combination of Capsaicin and Hesperidin Reduces the Effectiveness of Each Compound To Decrease the Adipocyte Size and To Induce Browning Features in Adipose Tissue of Western Diet Fed Rats.
    Journal of agricultural and food chemistry, 2018, Sep-19, Volume: 66, Issue:37

    Topics: Adipocytes; Adipose Tissue, White; Animals; Apoptosis Regulatory Proteins; Capsaicin; Cell Size; Color; Diet, Western; Drug Therapy, Combination; Hesperidin; Humans; Male; Obesity; Plant Extracts; Rats; Rats, Wistar; Uncoupling Protein 1

2018
A combination of glucosyl hesperidin and caffeine exhibits an anti-obesity effect by inhibition of hepatic lipogenesis in mice.
    Phytotherapy research : PTR, 2015, Volume: 29, Issue:2

    Topics: Adipogenesis; Adipose Tissue; Animals; Anti-Obesity Agents; Body Weight; Caffeine; Diet, High-Fat; Fatty Acid Synthases; Glucosides; Hesperidin; Lipids; Lipogenesis; Liver; Male; Mice; Mice, Obese; Obesity; Sterol Regulatory Element Binding Protein 1

2015
Citrus flavonoids repress the mRNA for stearoyl-CoA desaturase, a key enzyme in lipid synthesis and obesity control, in rat primary hepatocytes.
    Lipids in health and disease, 2011, Feb-23, Volume: 10

    Topics: Animals; Citrus; Enzyme Repression; Flavones; Gene Expression Regulation, Enzymologic; Hepatocytes; Hesperidin; Lipids; Liver; Male; Obesity; Rats; Rats, Sprague-Dawley; RNA, Messenger; Stearoyl-CoA Desaturase

2011
[Risk factors of chronic venous insufficiency of the lower extremities and possibilities of its medication in therapeutic practice].
    Terapevticheskii arkhiv, 2006, Volume: 78, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Bandages; Chronic Disease; Constipation; Diosmin; Drug Combinations; Exercise Therapy; Female; Hesperidin; Humans; Incidence; Leg; Male; Middle Aged; Obesity; Risk Factors; Sex Factors; Treatment Outcome; Venous Insufficiency

2006